Please assess the completion status of the following clinical trial:

Trial Title: Intranasal Fentanyl Versus Oral Morphine Sulfate in the Treatment of Pain in Pediatric Trauma

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patient aged between 4 years old and 15,3 years old~* Acute pain in traumatic context with a suspicion of fracture for patient \<7years old : feeling Pain \>6/10 defined with a face analogue scale and a visual analogic scale (the difference between the scales is not \<10 points)~* For patients \>7 years old : feeling pain \>6 points and defined thanks to a visual analogic scale~* Informed consent form signed by parents~* Beneficiary of an european health protection~Exclusion Criteria:~* Antalgic ( II or III) within 4 hours before the inclusion~* Allergic or non-indication of fentanyl~* Allergic or contraindication of morphine sulfate~* Pre existing peripheral intravenous catheter~* Traumatic brain injury~* Nasal traumatic

- Gender: ALL
- Minimum Age: 4 Years
- Maximum Age: 15 Years
- Healthy Volunteers: f

Study Arms:
- Intranasal fentanyl + Oral placebo (Type: EXPERIMENTAL): Administration of intranasal fentanyl (1.5µg/kg) and oral placebo in children with acute pain in traumatic context on arrival in emergency pediatric department.
- Oral morphine + Intranasal placebo (Type: ACTIVE_COMPARATOR): Administration of oral morphine (0.4mg/kg) and intranasal placebo in children with acute pain in traumatic context on arrival in emergency pediatric department.

Based on this trial design, predict the completion outcome and termination type (if applicable).